You are here
Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference
NEW YORK and CLEVELAND, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company developing novel cell and gene therapies for serious diseases, today announced that João Siffert, M.D., Chief Executive Officer, will participate in a fireside chat at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Wednesday, February 27, 2019 at 1:00 p.m. ET.
Friday, February 22, 2019 - 08:01